Constitutive activity of the δ-opioid receptor expressed in C6 glioma cells: Identification of non-peptide δ-inverse agonists

British Journal of Pharmacology

Volumn 128, Issue 3, 1999, Pages 556-562

  Neilan, Claire L ^a   Akil, Huda ^a   Woods, James H ^a   Traynor, John R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

opioid receptor; opioid receptor; Constitutive activity; G protein; Inverse agonism; Pertussis toxin

Indexed keywords

7 BENZYLIDENENALTREXONE; BUPRENORPHINE; CLOCINNAMOX; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTA OPIATE RECEPTOR ANTAGONIST; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); GUANOSINE TRIPHOSPHATE DERIVATIVE; N,N DIALLYLTYROSYL 2 METHYLALANYL 2 METHYLALANYLPHENYLALANYLLEUCINE; NALOXONE; NALTRIBEN; NALTRINDOLE; PERTUSSIS TOXIN; SODIUM CHLORIDE; SODIUM ION;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GLIOMA CELL; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); NARCOTIC ANTAGONISTS; RADIOLIGAND ASSAY; RATS; RECEPTORS, OPIOID, DELTA; TUMOR CELLS, CULTURED;

EID: 0032749031     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702816     Document Type: Article

References (30)

1. APPELMANS, N., CARROLL, J.A., RANCE, M.J., SIMON, E.J. & TRAYNOR, J.R. (1986). Sodium ions increase the binding of the antagonist peptide ICI 174,864 to the delta opiate receptor. Neuropeptides, 7, 139-143.
2. CHILDERS, S.R. & SNYDER, S.H. (1980). Differential regulation by guanine nucleotides of opiate agonist and antagonist receptor interactions. J. Neurochem., 34, 583-593.
3. CHIU, T.T., YUNG, L.Y. & WONG, Y.H. (1996). Inverse agonist effect of ICI 174,864 on the cloned δ-opioid receptor: Role of G-protein and adenylyl cyclase activation. Mol. Pharmacol., 50, 1651-1657.
4. CLARK, M.J., EMMERSON, P.J., MANSOUR, A., AKIL, H., WOODS, J.H., PORTOGHESE, P.S., REMMERS, A.E. & MEDZIHRADSKY, F. (1997). Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor. J. Pharmacol. Exp. Ther., 283, 501-510.
5. COMER, S.D., BURKE, T.F., LEWIS, J.W. & WOODS, J.H. (1992). Clocinnamox: a novel, systemically active, irreversible opioid antagonist. J. Pharmacol. Exp. Ther., 262, 1051-1056.
6. COSTA, T. & HERZ, A. (1989). Antagonists with negative intrinsic efficacy at δ opioid receptors coupled to GTP-binding proteins. Proc. Natl. Acad. Sci., 86, 7321-7325.
7. DHAWAN, B.N., CESSELIN, R., RAGHUBIR, R., REISINE, T., BRADLEY, P.B., PORTOGHESE, P.S. & HAMON, M. (1996). International union of pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev., 48, 567-592.
8. EMMERSON, P.J., CLARK. M.J., MANSOUR, A., AKIL, H., WOODS, J.H. & MEDZIHRADSKY, F. (1996). Characterisation of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor. J. Pharmacol. Exp. Ther., 278, 1121-1127.
9. GEORGOUSSI, Z. & ZIOUDROU, C. (1993). Effect of delta-opioid antagonists on the functional coupling between opioid receptors and G-proteins in rat brain membranes. Biochem. Pharmacol., 45, 2405-2410.
10. KATADA, T., OINUMA, M. & UI, M. (1986). Mechanism for the inhibition of ihe catalytic activity of the enzyme adenylate cyclase by the guanine nucleotide binding proteins serving as the substrate of the islet activating protein, pertussis toxin. J. Biol. Chem., 261, 5215-5221.
11. LAUGWITZ, K.-L., OFFERMANS, S., SPICHER, K. & SCHULTZ, G. (1993). μ and δ opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells. Neuron, 10, 233-242.
12. LEFF, P. (1995). The two-state model of receptor activation. Trends Pharmacol. Sci., 16, 89-97.
13. LEFKOWITZ, R.J., COTECCHIA, S., SAMAMA, P. & COSTA, T. (1993). Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci., 14, 203-207.
14. 35S] binding. J. Pharmacol. Exp. Ther., 285, 119-126.
15. MENG, F., HOVERSTEN, M., THOMPSON, R.C., TAYLOR, L., WATSON, S.J. & AKIL, H. (1995). A chimeric study of the molecular basis of affinity and selectivity of the κ and the δ opioid receptors: potential role of extracellular domains. J. Biol. Chem., 270, 12730-12736.
16. MERKOURIS, M., MULLANEY, I., GEORGOUSSI, Z. & MILLIGAN, G. (1997). Regulation of spontaneous activity of the δ-opioid receptor: Studies of inverse agonism in intact cells. J. Neurochem., 69, 2115-2122.
17. MULLANEY, I., CARR, C. & MILLIGAN, G. (1996). Analysis of inverse agonism at the δ opioid receptor after expression in Rat I fibroblasts. Biochem. J., 315, 227-234.
18. NEILAN, C.L., VIVIAN, J.A., WOODS, J.H. & TRAYNOR, J.R. (1998). Constitutive activity at opioid receptors expressed in C6 glioma cells. Society for Neuroscience Abstracts, 24, 2053.
19. 3H]opiate agonist binding by divalent cations. Mol. Pharm., 11, 735-744.
20. 1-opioid receptor antagonist: 7-benzylidenenaltrexone. Eur. J. Pharmacol., 218, 195-196.
21. SHAW, J.S., MILLER, L., TURNBULL, M.J., GORMLEY, J.J. & MORLEY, J.S. (1982). Selective antagonists at the opiate delta-receptor. Life. Sci., 31, 1259-1262.
22. SOFUOGLU, M., PORTOGHESE, P.S. & TAKEMORI, A.E. (1991). Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes. J. Pharmacol. Exp. Ther., 257, 676-680.
23. STICKLE, D. & BARBER, R. (1992). The encounter coupling model for β-adrenergic receptor/GTP binding protein interaction in the S49 cell. Calculation of the encounter frequency. Biochem. Pharmacol., 43, 2015-2028.
24. 35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects. J. Pharmacol. Exp. Ther., 283, 1276-1284.
25. THOMPSON, R.C., MANSOUR, A., AKIL, H. & WATSON, S.J. (1993). Cloning and pharmacological characterization of a rat μ-opioid receptor. Neuron, 11, 903-913.
26. 35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol. Pharmacol., 47, 848-854.
27. 3H]Diprenorphine binding to kappa sites in guinea-pig and rat brain: evidence for apparent heterogeneity. J. Neurochem., 53, 173-178.
28. WANG, Z., BILSKY, E.J., PORRECA, F. & SADEE, W. (1994). Constitutive mu opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence. Life Sci., 50, 339-350.
29. ZERNIG, G., BROADBEAR, J., BRINE, G.A., LEWIS, J.W. & WOODS, J.H. (1995). Opioid agonist effects on mouse writhing after irreversible mu receptor blockade with clocinnamox. Exp. Clin. Psychopharm., 3, 323-329.
30. ZERNIG, G., BURKE, T., LEWIS, J.W. & WOODS, J.H. (1996). Mechanism of clocinnamox blockade of opioid receptors: Evidence from in vitro and ex vivo binding and behavioral assays. J. Pharmacol. Exp. Ther., 279, 23-31.